PLA2G2A and COVID-19: Besides expanding the breath of the eicosanoid storm that characterises sepsis, we identify immuno‐lipidic hubs that promote inflammation – sPLA2, PGD2 and 12‐HETE – and exhibit relative specificity for COVID‐19.